References
- Arita K, Kurisu K, Tominaga A, Sugiyama K, Eguchi K, Hama S, et al. : Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma. Hiroshima J Med Sci 53 : 23-27, 2004
- Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR : Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 16 : 253-260, 2000
- Bergers G, Benjamin LE : Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 : 401-410, 2003 https://doi.org/10.1038/nrc1093
- Biousse V, Newman NJ, Oyesiku NM : Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71 : 542-545, 2001 https://doi.org/10.1136/jnnp.71.4.542
- Bonneville JF, Cattin F, Gorczyca W, Hardy J : Pituitary microadenomas: early enhancement with dynamic CT--implications of arterial blood supply and potential importance. Radiology 187 : 857-861, 1993 https://doi.org/10.1148/radiology.187.3.8497646
- Ferrara N : Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25 : 581-611, 2004 https://doi.org/10.1210/er.2003-0027
- Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, Forsham PH : Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma. J Clin Endocrinol Metab 52 : 95-97, 1981 https://doi.org/10.1210/jcem-52-1-95
- Garcia de la Torre N, Wass JA, Turner HE : Antiangiogenic effects of somatostatin analogues. Clin Endocrinol (Oxf) 57 : 425-441, 2002 https://doi.org/10.1046/j.1365-2265.2002.01619.x
- Gorczyca W, Hardy J : Microadenomas of the human pituitary and their vascularization. Neurosurgery 22 : 1-6, 1988 https://doi.org/10.1227/00006123-198801000-00001
- Gould VE, Wagner BM : Angiogenesis: an expanding universe. Hum Pathol 33 : 1061-1063, 2002 https://doi.org/10.1053/hupa.2002.130311
- Hicklin DJ, Ellis LM : Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23 : 1011-1027, 2005 https://doi.org/10.1200/JCO.2005.06.081
- Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. : Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340 : 1120-1124, 1992 https://doi.org/10.1016/0140-6736(92)93150-L
- Liotta LA, Steeg PS, Stetler-Stevenson WG : Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 : 327-336, 1991 https://doi.org/10.1016/0092-8674(91)90642-C
- Liu ZH, Chang CN, Pai PC, Wei KC, Jung SM, Chen NY, et al. : Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy. J Clin Neurosci 17 : 694-699, 2010 https://doi.org/10.1016/j.jocn.2009.11.012
- Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L : Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10 : 229-235, 1999 https://doi.org/10.1007/BF02738884
- Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, et al. : Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 74 : 95-105, 2001 https://doi.org/10.1159/000054675
- Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA : Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340 : 145-146, 1992 https://doi.org/10.1016/0140-6736(92)93217-B
- McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, et al. : Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87 : 4238-4244, 2002 https://doi.org/10.1210/jc.2002-020309
- Mohr G, Hardy J : Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 18 : 181-189, 1982 https://doi.org/10.1016/0090-3019(82)90388-3
- Murad-Kejbou S, Eggenberger E : Pituitary apoplexy: evaluation, management, and prognosis. Curr Opin Ophthalmol 20 : 456-461, 2009 https://doi.org/10.1097/ICU.0b013e3283319061
- Nawar RN, AbdelMannan D, Selman WR, Arafah BM : Pituitary tumor apoplexy: a review. J Intensive Care Med 23 : 75-90, 2008 https://doi.org/10.1177/0885066607312992
- Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, et al. : Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF) : A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A 99 : 383-388, 2002 https://doi.org/10.1073/pnas.012074399
- Ostrov SG, Quencer RM, Hoffman JC, Davis PC, Hasso AN, David NJ : Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJR Am J Roentgenol 153 : 153-160, 1989 https://doi.org/10.2214/ajr.153.1.153
- Pizarro CB, Oliveira MC, Pereira-Lima JF, Leães CG, Kramer CK, Schuch T, et al. : Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology 29 : 40-44, 2009 https://doi.org/10.1111/j.1440-1789.2008.00937.x
- Semple PL, Jane JA, Lopes MB, Laws ER : Pituitary apoplexy : correlation between magnetic resonance imaging and histopathological results. J Neurosurg 108 : 909-915, 2008 https://doi.org/10.3171/JNS/2008/108/5/0909
- Tammela T, Enholm B, Alitalo K, Paavonen K : The biology of vascular endothelial growth factors. Cardiovasc Res 65 : 550-563, 2005 https://doi.org/10.1016/j.cardiores.2004.12.002
- Turgut M, Ozsunar Y, Basak S, Guney E, Kir E, Meteoglu I : Pituitary apoplexy : an overview of 186 cases published during the last century. Acta Neurochir (Wien) 152 : 749-761, 2010 https://doi.org/10.1007/s00701-009-0595-8
- Turner HE, Harris AL, Melmed S, Wass JA : Angiogenesis in endocrine tumors. Endocr Rev 24 : 600-632, 2003 https://doi.org/10.1210/er.2002-0008
- Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA : Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85 : 1159-1162, 2000 https://doi.org/10.1210/jc.85.3.1159
- Verrees M, Arafah BM, Selman WR : Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 16 : E6, 2004
- Wakai S, Fukushima T, Teramoto A, Sano K : Pituitary apoplexy : its incidence and clinical significance. J Neurosurg 55 : 187-193, 1981 https://doi.org/10.3171/jns.1981.55.2.0187
- Wakai S, Yamakawa K, Manaka S, Takakura K : Spontaneous intracranial hemorrhage caused by brain tumor : its incidence and clinical significance. Neurosurgery 10 : 437-444, 1982 https://doi.org/10.1227/00006123-198204000-00004
- Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J : Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143 : 401-409, 1993
- Yamada S, Takada K : Angiogenesis in pituitary adenomas. Microsc Res Tech 60 : 236-243, 2003 https://doi.org/10.1002/jemt.10262
Cited by
- The Prevalence and Natural History of Pituitary Hemorrhage in Prolactinoma vol.98, pp.6, 2013, https://doi.org/10.1210/jc.2013-1249
- Dissociated hypopituitarism after spontaneous pituitary apoplexy in acromegaly vol.17, pp.7, 2011, https://doi.org/10.4103/2230-8210.119518
- Pituitary apoplexy in a patient with suspected metastatic bronchogenic carcinoma vol.2014, pp.None, 2014, https://doi.org/10.1136/bcr-2013-202803
- Pituitary Apoplexy Secondary to Thrombocytopenia Due to Dengue Hemorrhagic Fever: A Case Report and Review of the Literature vol.20, pp.4, 2011, https://doi.org/10.4158/ep13319.cr
- Pituitary intratumoral hemorrhage during radiation therapy following partial removal of giant pituitary adenoma: A case report vol.3, pp.1, 2011, https://doi.org/10.4236/crcm.2014.31010
- Pituitary intratumoral hemorrhage during radiation therapy following partial removal of giant pituitary adenoma: A case report vol.3, pp.1, 2011, https://doi.org/10.4236/crcm.2014.31010
- Endocan, a new invasion and angiogenesis marker of pituitary adenomas vol.117, pp.3, 2011, https://doi.org/10.1007/s11060-014-1377-6
- Multicenter Study on Adult Growth Hormone Level in Postoperative Pituitary Tumor Patients vol.71, pp.2, 2015, https://doi.org/10.1007/s12013-014-0334-5
- Pituitary Apoplexy vol.36, pp.6, 2015, https://doi.org/10.1210/er.2015-1042
- Pseudotumor cerebri and pituitary apoplexy vol.115, pp.3, 2011, https://doi.org/10.1007/s13760-014-0393-9
- Pituitary Apoplexy After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitor: A Novel Complication vol.76, pp.2, 2011, https://doi.org/10.1055/s-0035-1554909
- MRI in the Evaluation of Acute Visual Syndromes vol.24, pp.6, 2015, https://doi.org/10.1097/rmr.0000000000000070
- Investigation of the growth patterns of non-functioning pituitary macroadenomas using volumetric assessments on serial MRI investigations vol.20, pp.1, 2011, https://doi.org/10.4102/sajr.v20i1.962
- Selective molecular biomarkers to predict biologic behavior in pituitary tumors vol.12, pp.3, 2011, https://doi.org/10.1080/17446651.2017.1312341
- Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer vol.19, pp.12, 2011, https://doi.org/10.1080/15384047.2018.1491497
- Landscape of Molecular Events in Pituitary Apoplexy vol.9, pp.None, 2011, https://doi.org/10.3389/fendo.2018.00107
- Imatinib Inhibits GH Secretion From Somatotropinomas vol.9, pp.None, 2011, https://doi.org/10.3389/fendo.2018.00453
- PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age vol.41, pp.None, 2011, https://doi.org/10.1016/j.anndiagpath.2019.04.016